Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study.

Biomedicines·2026
Same author

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Nature communications·2026
Same author

Evaluation of Drug-Drug Interactions Using Drug-PIN® in Patients Receiving Avelumab Maintenance for Advanced Urothelial Carcinoma: Evidence from the MALVA Study (Meet-URO 25).

Oncology and therapy·2026
Same author

Gut microbiome dysbiosis and cancer: A systematic review on the emerging role of probiotics in oncology.

Critical reviews in oncology/hematology·2026
Same author

Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.

Breast (Edinburgh, Scotland)·2026
Same author

Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.

The oncologist·2026

相关实验视频

Updated: Jul 20, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K

流动经济景观中的网络方法

Daniele Santini1, Andrea Botticelli1, Antonio Galvano2

  • 1Oncologia Medica A, Policlinico Umberto 1, La Sapienza Università Di Roma, Rome, Italy.

Journal of experimental & clinical cancer research : CR
|August 4, 2023
PubMed
概括

液体活检为癌症分子分析提供了一种不那么侵入性的组织活检替代方案. 这种方法在癌症查,诊断和治疗选择方面显示出前景,尽管目前存在标准化挑战.

关键词:
在CTC中,使用CTC.液体活检液体活检流动性经济学 (Liquidomics) 是一种流动性经济学.在MRD中,我们可以使用MRD.有针对性的治疗.ctDNActDNA是什么意思

更多相关视频

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.0K
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K

相关实验视频

Last Updated: Jul 20, 2025

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

2.4K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.0K
Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
10:37

Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification

Published on: November 15, 2017

12.0K

科学领域:

  • 在瘤学瘤学.
  • 分子诊断学 分子诊断学
  • 基因组学就是基因组学.

背景情况:

  • 组织活检是侵入性的,并且对于频繁的癌症分子分析有局限性.
  • 癌症不断变化的基因组特征需要更少的侵入性和更准确的诊断替代方案.
  • 液体活检,分析循环瘤细胞和体液中的核酸,成为一个有希望的替代方案.

研究的目的:

  • 审查有关各种液体活检形式的局限性和优点的当前知识.
  • 讨论将液体活检纳入常规癌症管理中的问题.
  • 突出新型生物标志物和液体活检在瘤学中的未来影响.

主要方法:

  • 审查现有的关于液体活检技术和应用的文献.
  • 在体液中分析循环瘤DNA (ctDNA) 和循环瘤细胞 (CTC).
  • 探索用于治疗反应和疾病监测的生物标志物.

主要成果:

  • 液体活检在癌症查,诊断,预后和复发风险评估方面显示出有希望的结果.
  • 识别治疗反应的预测生物标志物 (例如EGFR,KRAS突变,MSI/MMR).
  • 通过纵向ctDNA监测,可以预测最小的残留疾病和复发风险.

结论:

  • 液体活检是一个快速发展的领域,在临床瘤学中具有显著的潜力.
  • 工作流程的标准化对于可重复性和广泛的临床采用至关重要.
  • 液体活检为个性化癌症护理提供了一种不那么侵入性的,更容易获得的瘤分子分析方法.